Médecins Dr. Christine Haie-Meder

Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy

DOI:10.1016/j.ygyno.2020.03.006

Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects.

DOI:10.1016/j.semradonc.2019.08.009

Recommendations from gynaecological (GYN) GEC-ESTRO working group – ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer

DOI: 10.1016/j.radonc.2019.11.005

Place of radiotherapy and surgery in the treatment of cervical cancer patients

DOI: 10.1016/j.canrad.2019.07.151

Multimodal imaging guided brachytherapy: the example of cervical cancer

DOI: 10.1016/j.canrad.2019.07.145

Brachytherapy: An overview for clinicians

DOI: 10.3322/caac.21578

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.

DOI: 10.1016/S1470-2045(19)30395-X

Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study.

DOI: 10.1016/j.ijrobp.2019.03.038

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation

DOI: 10.2147/CMAR.S195989

Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort

DOI: 10.1016/j.radonc.2019.02.007